Cornerstone Capital Management Holdings’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-51,768	Closed	-$6.38M	–	1416
2014 Q2	$6.38M	Buy	51,768 +12,697	+32%	+$1.4M	0.07%	366
2014 Q1	$4.05M	Buy	+39,071	New	+$4M	0.05%	440
2013 Q4	–	Sell	-41,262	Closed	-$2.76M	–	1395
2013 Q3	$2.76M	Sell	41,262 -10,283	-20%	-$709K	0.03%	559
2013 Q2	$3.41M	Buy	+51,545	New	+$2.95M	0.04%	496

Other funds holding SLXP

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Cornerstone Capital Management Holdings's SLXP Position: Q3 2014 in Review

Cornerstone Capital Management Holdings sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q3 2014, closing a stake of 51,768 shares — an estimated $6.38M sold.

Cornerstone Capital Management Holdings first reported a position in SLXP in Q2 2013 and held it in 4 quarters. The position peaked at $6.38M in Q2 2014. 348 funds tracked by Wall St. Rank hold SLXP as of Q3 2014.

Cornerstone Capital Management Holdings reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q3 2014 after selling out during the quarter.
Cornerstone Capital Management Holdings sold 51,768 SALIX PHARMACEUTICALS LTD DEL shares in Q3 2014, an estimated $6.38M.
Cornerstone Capital Management Holdings first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 4 quarters.
Cornerstone Capital Management Holdings's SALIX PHARMACEUTICALS LTD DEL position peaked at $6.38M in Q2 2014.
348 funds tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q3 2014.

Based on Cornerstone Capital Management Holdings's 13F filing for Q3 2014, filed 14 Nov 2014.